GORE® EXCLUDER® Conformable AAA Endoprosthesis Obtains CE Mark
Continually expanding clinicians’ options in the endovascular treatment of patients with aortic disease
GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval
Global reach expanded for the solution that physicians trust and patients count on
Gore Global Registry for Endovascular Aortic Treatment Enrolls 3,000 Patients
Midpoint findings to be released at 2015 Vascular Annual Meeting in Chicago
GORE® EXCLUDER® Device Reaches Significant Milestone
Proven device for endovascular aneurysm repair (EVAR) reaches 250,000 patients worldwide
Gore Receives FDA Clearance for GORE® SYNECOR Preperitoneal Biomaterial Hernia Repair Device
Hybrid of unique bioabsorbable and permanent materials provide a single-stage hernia repair to help minimize complications in preperitoneal applications
Gore Joins Vascular and Endovascular Leaders in Recognizing the 2014 Pioneers in Performance for North America
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
Gore Launches Unique Biomaterial for Complex Ventral Hernia Repair
Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.
Nominees Announced for 2013-2014 Pioneers in Performance Awards for Europe; Online Voting Opens at PioneersInPerformance.com
Charing Cross International Symposium
GORE® EXCLUDER® Iliac Branch Endoprosthesis Approved in Japan
Gore designed All-in-One System to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
New Technology Add-On Payment Awarded for GORE® EXCLUDER® Iliac Branch Endoprosthesis
Recognition of new technology status will provide additional hospital reimbursement for IBE when used in FDA approved indications